{"gene":"MAOA","run_date":"2026-06-10T02:59:50","timeline":{"discoveries":[{"year":1995,"finding":"MAOA knockout mice (generated by transgene-insertion deletion) show up to ninefold elevation of brain serotonin and twofold elevation of norepinephrine in pup brains, demonstrating that MAOA is the primary enzyme responsible for degrading serotonin and norepinephrine in vivo. Loss of MAOA also causes cytoarchitectural changes in the somatosensory cortex and enhanced aggression in adult males; the behavioral alterations in pups were reversed by the serotonin synthesis inhibitor parachlorophenylalanine, placing elevated serotonin causally upstream of the behavioral phenotype.","method":"Transgenic knockout mouse (gene deletion via transgene integration), neurochemical quantitation, serotonin-like immunohistochemistry, pharmacological rescue with parachlorophenylalanine","journal":"Science","confidence":"High","confidence_rationale":"Tier 1-2 / Strong — in vivo genetic knockout with neurochemical quantitation, pharmacological rescue, and histological validation; highly cited foundational study replicated across multiple labs","pmids":["7792602"],"is_preprint":false},{"year":1999,"finding":"MAO-A preferentially oxidizes serotonin (5-HT) and norepinephrine (NE), whereas MAO-B preferentially oxidizes phenylethylamine (PEA). MAO-A KO mice have elevated brain levels of 5-HT, NE, and DA and manifest aggressive behavior; MAO-B KO mice show increased PEA only and do not exhibit aggression, demonstrating distinct substrate specificities and behavioral roles for the two isoenzymes.","method":"MAO-A and MAO-B knockout mice (transgenic deletion and homologous recombination), neurochemical measurements of brain monoamine levels, behavioral assays","journal":"Neurobiology (Budapest)","confidence":"High","confidence_rationale":"Tier 1-2 / Strong — two independent KO models with neurochemical and behavioral endpoints, directly comparing MAO-A vs MAO-B substrate selectivity in vivo","pmids":["10591056"],"is_preprint":false},{"year":1988,"finding":"The human MAOA gene was mapped to chromosomal region Xp21-p11 using rodent-human somatic cell hybrids, and the gene encodes an enzyme located in the outer mitochondrial membrane responsible for degradative metabolism of biogenic amines throughout the body. An RFLP was identified for this locus.","method":"Southern blot analysis, rodent-human somatic cell hybrids, chromosomal mapping","journal":"Genomics","confidence":"High","confidence_rationale":"Tier 2 / Strong — direct chromosomal localization by somatic cell hybrid panel; widely replicated finding","pmids":["2906043"],"is_preprint":false},{"year":1996,"finding":"Mutational analysis of the human MAOA coding sequence in 40 control males with >100-fold variation in MAO-A enzyme activity (measured in cultured skin fibroblasts) revealed high conservation, with only 5 polymorphisms, all but one at synonymous positions. The one amino acid change (Lys→Arg) was neutral, demonstrating that coding sequence variation does not account for normal population variation in MAO-A activity.","method":"RT-PCR, SSCP, sequencing of mRNA/genomic DNA, MAO-A activity assay in cultured skin fibroblasts","journal":"American journal of medical genetics","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — direct enzymatic activity measurement correlated with coding sequence in 40 individuals; single lab but multiple methods","pmids":["8678123"],"is_preprint":false},{"year":2016,"finding":"Elucidation of the molecular structure of the active sites of MAO-A and MAO-B has enabled precise determination of how substrates and inhibitor molecules are metabolized or inhibit substrate metabolism. Reversible MAO-A inhibitors (e.g., moclobemide) lack the 'cheese effect' (tyramine pressor potentiation) seen with irreversible inhibitors, attributed to differences in binding mechanism at the active site.","method":"Review of crystal structure data and pharmacological characterization of inhibitor-enzyme interactions","journal":"Frontiers in pharmacology","confidence":"Medium","confidence_rationale":"Tier 1 / Weak — structural and pharmacological data synthesized in review; active-site structure established by original crystallography studies cited therein but not primary data in this paper","pmids":["27803666"],"is_preprint":false},{"year":2019,"finding":"Meta-analysis and systematic review established that the MAOA 5' VNTR polymorphism is robustly associated with MAO-A enzyme activity (medium to large effect), confirming that this promoter VNTR is a functional polymorphism that directly affects the abundance/activity of the MAOA gene product.","method":"Systematic review and meta-analysis of 255 eligible studies measuring polymorphism effects on gene product expression, abundance, activity, or affinity","journal":"Biological psychiatry","confidence":"High","confidence_rationale":"Tier 2 / Strong — meta-analysis of multiple independent studies measuring enzyme activity directly; robust and replicated across many labs","pmids":["31303260"],"is_preprint":false},{"year":2015,"finding":"MAOA promotes prostate cancer cell invasion through a MAOA/mTOR/HIF-1α signaling pathway that exploits reactive oxygen species (ROS). Cancer-associated fibroblasts (CAFs) induce prostate cancer EMT and invasion via this pathway, and curcumin abrogates CAF-induced invasion by inhibiting MAOA/mTOR/HIF-1α signaling and suppressing ROS production.","method":"In vitro invasion and EMT assays, ROS measurement, CXCR4 and IL-6 receptor expression analysis, pharmacological inhibition with curcumin","journal":"International journal of oncology","confidence":"Medium","confidence_rationale":"Tier 3 / Moderate — multiple in vitro assays in single lab; pathway placement via pharmacological inhibition without genetic rescue","pmids":["26499200"],"is_preprint":false},{"year":2018,"finding":"Loss of MAOA in prostate epithelia (Pten/MAOA double KO mouse model) significantly decreases prostate tumor size and invasive cancer incidence, reduces AKT phosphorylation and Ki67, and suppresses cancer stem cell markers (OCT4, NANOG, CD44, α2β1, CD133, HIF-1α). Targeted MAOA knockdown (shRNA/siRNA) in prostate cancer cells confirms reduced spheroid formation, establishing that MAOA promotes cell proliferation and cancer stem cell maintenance via the PTEN/AKT pathway.","method":"Conditional prostate-specific double knockout mouse model (Pten/MAOA KO), shRNA knockdown, siRNA knockdown, colony formation assay, immunohistochemistry for stem cell markers, Western blot for AKT phosphorylation","journal":"Oncogene","confidence":"High","confidence_rationale":"Tier 2 / Strong — in vivo genetic KO model plus multiple in vitro genetic knockdown approaches with orthogonal readouts; single lab but multiple methods","pmids":["29844571"],"is_preprint":false},{"year":2021,"finding":"MAOA promotes perineural invasion (PNI) of prostate cancer cells through a mechanism whereby MAOA activates SEMA3C transcription in a Twist1-dependent manner; SEMA3C then stimulates cMET via autocrine/paracrine interaction with co-activated PlexinA2 and NRP1 co-receptors. MAOA inhibitor treatment reduces PNI in vitro and tumor-infiltrating nerve fiber density in an orthotopic xenograft model.","method":"In vitro PNI assay, orthotopic xenograft mouse model, gene expression analysis, MAOA inhibitor treatment, mechanistic pathway dissection","journal":"Oncogene","confidence":"High","confidence_rationale":"Tier 2 / Strong — in vitro and in vivo models, defined molecular pathway (MAOA→Twist1→SEMA3C→PlexinA2/NRP1→cMET) with multiple orthogonal approaches","pmids":["33420365"],"is_preprint":false},{"year":2020,"finding":"MAOA in stromal fibroblasts elevates reactive oxygen species production, triggers IL-6 activation, and promotes prostate tumorigenesis via paracrine IL-6/STAT3 signaling. Mechanistically, MAOA enhances IL-6 transcription through direct Twist1 binding to a conserved E-box element at the IL-6 promoter. Downstream STAT3 transcriptionally activates CD44 expression in prostate cancer cells.","method":"In vitro co-culture, in vivo tumor models, ChIP (Twist1 binding to IL-6 promoter E-box), Western blot, tissue microarray analysis","journal":"Oncogene","confidence":"High","confidence_rationale":"Tier 2 / Strong — direct ChIP evidence for Twist1-E-box interaction, in vitro and in vivo models, paracrine signaling mechanism defined with multiple methods","pmids":["32066880"],"is_preprint":false},{"year":2021,"finding":"MAOA and androgen receptor (AR) form a positive feedback regulatory circuit in prostate cancer: androgens induce MAOA expression through direct AR binding to a novel intronic androgen response element (ARE) in the MAOA gene; in turn, MAOA promotes AR transcriptional activity via upregulation of Shh/Gli-YAP1 signaling, enhancing nuclear YAP1-AR interactions. Silencing MAOA suppresses AR-mediated prostate cancer growth including CRPC in mice.","method":"ChIP (AR binding to intronic ARE), reporter assay, siRNA/shRNA silencing, in vivo mouse models (androgen-dependent and CRPC), pharmacological combination studies","journal":"Cancer research","confidence":"High","confidence_rationale":"Tier 2 / Strong — direct ChIP evidence for AR-ARE binding, multiple genetic and pharmacological approaches, in vitro and in vivo validation of pathway","pmids":["34167949"],"is_preprint":false},{"year":2017,"finding":"MAOA is a direct target gene of REST (repressor element-1 silencing transcription factor) in prostate cancer cells. Overexpressed MAOA produces reactive oxygen species (ROS) that inhibit apoptosis and activate autophagy in neuroendocrine-differentiated prostate cancer cells. MAOA inhibitors reduce neuroendocrine differentiation and autophagy activation.","method":"Reporter assay, siRNA knockdown, MAOA inhibitor treatment, ROS measurement, apoptosis and autophagy assays","journal":"Scientific reports","confidence":"Medium","confidence_rationale":"Tier 3 / Moderate — single lab, multiple in vitro assays; REST-MAOA direct target relationship established by reporter assay","pmids":["28402333"],"is_preprint":false},{"year":2018,"finding":"In breast cancer, IL-6/IL-6R signaling in hypoxic conditions causes sustained inhibition of MAO-A. Inhibition of IL-6R signaling or IL-6R siRNA increased MAO-A activity and inhibited tumor angiogenesis and invasion. Elevation of MAO-A with 5-azacytidine modulated IL-6-mediated angiogenesis and invasive signatures (VEGF, MMPs, EMT). This establishes MAO-A as a suppressor of tumor angiogenesis and invasion downstream of IL-6/IL-6R in hypoxic breast cancer.","method":"In vitro and in vivo assays, IL-6R siRNA knockdown, 5-azacytidine treatment, VEGF/MMP/EMT marker analysis, clinical specimen IHC","journal":"British journal of cancer","confidence":"Medium","confidence_rationale":"Tier 3 / Moderate — multiple in vitro and in vivo methods; IL-6R→MAO-A axis supported by siRNA knockdown and pharmacological elevation in single lab","pmids":["29695771"],"is_preprint":false},{"year":2018,"finding":"IL-13 stimulation of primary human monocytes and A549 lung carcinoma cells co-induces MAO-A expression with 15-lipoxygenase (15-LO). MAO-A gene expression and activity are regulated by STAT1, STAT3, STAT6, EGR1, and CREB. In monocytes and A549 cells, IL-13-driven MAO-A expression, activity, and function (including cell migration and ROS generation) are governed by 15-LO in a PPARγ-dependent manner, with STAT6 facilitating PPARγ transcriptional activity (IL-13→STAT6→15-LO→PPARγ→MAO-A axis).","method":"Primary human monocyte culture, A549 cell line, siRNA knockdown of STAT1/3/6, EGR1, CREB, 15-LO; MAO-A activity assay, ROS measurement, cell migration assay, reporter assay","journal":"Journal of Biological Chemistry","confidence":"High","confidence_rationale":"Tier 2 / Strong — multiple transcription factor knockdowns with enzymatic activity measurements, two cell types, defined IL-13→STAT6→15-LO→PPARγ→MAO-A pathway","pmids":["30021838"],"is_preprint":false},{"year":2012,"finding":"Acute psychosocial stress in healthy humans reduces whole-brain MAO-A binding (measured by [11C]harmine PET) in 10 of 11 brain regions. Correspondingly, acute dexamethasone exposure in human neuronal and glial cell lines decreases MAO-A activity and protein levels within 4 hours. This establishes that glucocorticoid signaling acutely downregulates MAO-A density and activity.","method":"[11C]harmine PET imaging in humans under acute stress, Western blot for MAO-A protein, [14C]-5-HT metabolism assay for MAO-A activity in neuronal/glial cell lines after dexamethasone exposure","journal":"Journal of Neuroscience","confidence":"High","confidence_rationale":"Tier 1-2 / Strong — in vivo PET imaging plus in vitro enzymatic activity assay with protein quantification; convergent human and cell-based evidence for glucocorticoid-mediated acute MAO-A downregulation","pmids":["23197705"],"is_preprint":false},{"year":2006,"finding":"MAOA is subject to monoallelic expression (X chromosome inactivation) in primary clonal cultures of human skin fibroblasts, as determined by RFLP analysis of clonal cell lines. This establishes that MAOA undergoes X-inactivation in normal human somatic cells, with implications for sex differences in MAO-A-related traits.","method":"Primary clonal cell cultures from human skin fibroblasts, RFLP analysis of allelic expression","journal":"Biochemical and biophysical research communications","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — direct allele-specific expression analysis in primary clonal cultures; single lab, single method","pmids":["16890910"],"is_preprint":false},{"year":2009,"finding":"X chromosome inactivation (XCI) status of MAOA was confirmed in normal human fibroblasts with skewed inactivation using allele-specific expression analysis and DNA methylation of the 5' end, demonstrating monoallelic expression and refuting earlier hybrid cell data suggesting escape from XCI.","method":"Human fibroblasts with skewed XCI, allele-specific expression analysis, DNA methylation analysis of 5' region","journal":"Epigenetics","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — two complementary methods (allele-specific expression and DNA methylation) in normal human cells; single lab","pmids":["19684479"],"is_preprint":false},{"year":2018,"finding":"Luciferase-based reporter gene assays demonstrated that methylation of the MAOA promoter region causes decreased reporter gene activity compared with unmethylated constructs, directly establishing that DNA methylation of the MAOA promoter functionally reduces MAOA transcription.","method":"Luciferase reporter gene assay using methylated vs. unmethylated pCpGfree_MAOA constructs","journal":"International journal of neuropsychopharmacology","confidence":"Medium","confidence_rationale":"Tier 1 / Weak — in vitro reporter assay establishing functional consequence of MAOA methylation; single lab, single method","pmids":["30169842"],"is_preprint":false},{"year":2023,"finding":"MAOA interacts with NDRG1 and suppresses the Warburg effect (glycolysis) in gastric cancer through inhibition of the PI3K/AKT/mTOR pathway. MAOA expression was negatively correlated with SUVmax values on PET-CT, and overexpression of MAOA promoted cancer cell apoptosis and inhibited tumor growth and glycolysis.","method":"Co-immunoprecipitation/protein interaction (MAOA-NDRG1), Western blot, Seahorse metabolic assay, in vitro and in vivo experiments, PI3K/AKT/mTOR pathway analysis","journal":"Cellular oncology","confidence":"Medium","confidence_rationale":"Tier 3 / Moderate — protein interaction and pathway placement established in single lab with multiple assays including metabolic measurement; mechanism partially defined","pmids":["37249744"],"is_preprint":false},{"year":2021,"finding":"MAO-A expression and activity are increased in the pulmonary vasculature of patients with PAH and in experimental PAH. Clorgyline (MAO-A inhibitor) treatment reduced RV afterload, pulmonary vascular remodeling, proliferation, and oxidative stress in SuHx rats, establishing that MAO-A promotes pulmonary vascular remodeling via ROS production.","method":"Human PAH lung tissue analysis, SuHx rat model, pulmonary trunk banding rat model, echocardiography, RV catheterization, clorgyline pharmacological inhibition, histological analysis","journal":"American journal of respiratory cell and molecular biology","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — in vivo animal models with pharmacological inhibition and multiple physiological/histological endpoints; single lab","pmids":["33264068"],"is_preprint":false},{"year":2024,"finding":"Glucocorticoids activate the PI3K/AKT pathway, which upregulates MAOA expression in trabecular meshwork cells; elevated MAOA then drives mitochondrial dysfunction, ROS production, and premature cellular senescence. PI3K inhibition or selective PIK3R1 silencing reduced DEX-induced MAOA expression and oxidative stress, placing MAOA downstream of PI3K/AKT in the glucocorticoid-induced senescence pathway.","method":"mRNA-seq/KEGG pathway analysis, PI3K inhibitor treatment, PIK3R1 siRNA silencing, ROS/mitochondrial superoxide measurement, cell cycle analysis, β-galactosidase staining, in vivo GIG mouse model","journal":"Aging cell","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — PI3K inhibition and genetic silencing with multiple cellular readouts; pathway placement of MAOA downstream of PI3K/AKT established in single lab","pmids":["39688282"],"is_preprint":false},{"year":2025,"finding":"Inhibition of stromal MAOA leads to increased WNT5A production in cancer-associated fibroblasts (CAFs), which activates CD8+ T cell cytotoxic capacity through Ca2+-NFATC1 signaling, thereby improving the immunosuppressive tumor microenvironment. MAOA inhibition in stromal cells also promotes conversion of myofibroblastic CAFs and synergizes with immune checkpoint inhibitors.","method":"Single-cell sequencing re-analysis, in vitro co-culture of stromal and immune cells, C57BL/6J subcutaneous tumor model, dual humanized mouse model, MAOA inhibitor treatment","journal":"Journal for immunotherapy of cancer","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — in vitro and in vivo models with mechanistic pathway (stromal MAOA→WNT5A→Ca2+-NFATC1→CD8+ T cell activation) defined in single lab","pmids":["40121032"],"is_preprint":false},{"year":2023,"finding":"TPhP (triphenyl phosphate) activates MAOA, leading to oxidative stress that activates NFκB and disrupts tryptophan metabolism (inhibiting tryptophan-serotonin pathway, activating tryptophan-kynurenine pathway) in trophoblast cells and mouse placenta. The MAOA inhibitor clorgyline mitigated TPhP-induced oxidative stress and reversed tryptophan metabolism disturbances, establishing MAOA as a key mediator of TPhP-induced ROS/NFκB-dependent tryptophan pathway disruption.","method":"JEG-3 trophoblast cell line, mouse intrauterine exposure model, clorgyline pharmacological inhibition, NFκB inhibitor sulfasalazine, NAC antioxidant, gene/protein expression analysis, metabolite measurement","journal":"Science of the Total Environment","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — pharmacological inhibition with MAOA inhibitor and pathway-specific inhibitors, confirmed in vivo in mouse model; single lab","pmids":["37659542"],"is_preprint":false},{"year":2012,"finding":"ApoE isoforms regulate melatonin biosynthesis in C6 glioma cells partly through MAOA: ApoE4-expressing cells show decreased MAOA (and MAOB) mRNA expression compared to ApoE3 cells, leading to reduced serotonin degradation and increased availability of the melatonin precursor, contributing to higher melatonin levels in ApoE4 cells.","method":"Stable ApoE isoform expression in C6 cells, mRNA expression analysis, melatonin and NAT protein measurement","journal":"Journal of pineal research","confidence":"Low","confidence_rationale":"Tier 3 / Weak — single lab, single cell line, mRNA expression only without direct enzymatic activity measurement of MAOA","pmids":["22225631"],"is_preprint":false}],"current_model":"MAOA encodes a mitochondrial flavoenzyme anchored to the outer mitochondrial membrane that catalyzes the oxidative deamination of monoamine neurotransmitters (serotonin, norepinephrine, dopamine) and dietary amines, generating hydrogen peroxide as a byproduct; the gene is X-linked (Xp11.3) and subject to X-chromosome inactivation, its expression is controlled by a functional 5' VNTR promoter polymorphism and by DNA methylation, and its activity is acutely downregulated by glucocorticoids; beyond neurotransmitter metabolism, MAOA-derived ROS activates mTOR/HIF-1α, PI3K/AKT, and Twist1/IL-6/STAT3 signaling to drive cancer cell proliferation, stemness, EMT, perineural invasion (via SEMA3C/PlexinA2/NRP1/cMET), and an immunosuppressive tumor microenvironment, while in the cardiovascular system elevated MAO-A promotes pulmonary vascular remodeling through oxidative stress."},"narrative":{"mechanistic_narrative":"MAOA encodes a flavoenzyme of the outer mitochondrial membrane that catalyzes the oxidative deamination of biogenic amines throughout the body [PMID:2906043], and is the primary enzyme degrading serotonin and norepinephrine in vivo: its genetic loss in mice produces large elevations of brain serotonin and norepinephrine, cortical cytoarchitectural changes, and aggression that is reversible by blocking serotonin synthesis [PMID:7792602]. MAO-A and MAO-B are distinguished by substrate preference, MAO-A favoring serotonin and norepinephrine [PMID:10591056], with active-site structure determining substrate handling and the differential pharmacology of reversible versus irreversible inhibitors [PMID:27803666]. The X-linked gene (Xp21-p11) is subject to X-chromosome inactivation in normal somatic cells [PMID:2906043, PMID:16890910, PMID:19684479], and its expression is set largely at the regulatory rather than coding level: coding variation does not explain population activity differences [PMID:8678123], whereas a functional 5' promoter VNTR governs enzyme activity [PMID:31303260] and promoter DNA methylation suppresses transcription [PMID:30169842]. Enzyme density and activity are acutely downregulated by glucocorticoid signaling, as shown by stress-induced reductions in brain MAO-A binding and dexamethasone-driven loss of MAO-A in neuronal and glial cells [PMID:23197705]. Beyond neurotransmitter catabolism, MAO-A-generated reactive oxygen species drive oncogenic signaling: in prostate cancer MAOA promotes proliferation and cancer stem-cell maintenance through PTEN/AKT [PMID:29844571], invasion through mTOR/HIF-1α [PMID:26499200], paracrine IL-6/STAT3 signaling via Twist1 binding the IL-6 promoter [PMID:32066880], perineural invasion through a Twist1→SEMA3C→PlexinA2/NRP1→cMET cascade [PMID:33420365], and a positive feedback loop with the androgen receptor via an intronic ARE and Shh/Gli-YAP1 signaling [PMID:34167949]. MAOA expression is itself controlled by transcription factors including REST [PMID:28402333] and an IL-13→STAT6→15-LO→PPARγ axis [PMID:30021838]. Context-dependent roles also exist, with MAO-A acting as a suppressor of angiogenesis and invasion downstream of IL-6R in hypoxic breast cancer [PMID:29695771] and restraining glycolysis through NDRG1 and PI3K/AKT/mTOR in gastric cancer [PMID:37249744]. In non-malignant tissues, elevated MAO-A drives pulmonary vascular remodeling through oxidative stress [PMID:33264068], glucocorticoid-induced senescence in trabecular meshwork cells downstream of PI3K/AKT [PMID:39688282], and ROS/NFκB-dependent disruption of placental tryptophan metabolism [PMID:37659542].","teleology":[{"year":1988,"claim":"Establishing the chromosomal location and subcellular identity of MAOA defined it as an X-linked outer-mitochondrial-membrane enzyme for biogenic amine catabolism.","evidence":"Southern blot and rodent-human somatic cell hybrid mapping to Xp21-p11","pmids":["2906043"],"confidence":"High","gaps":["Did not resolve substrate specificity versus MAO-B","No functional consequence of gene dosage established"]},{"year":1995,"claim":"Genetic ablation in mice answered whether MAOA is rate-limiting for serotonin/norepinephrine turnover in vivo and whether this drives behavior, placing elevated serotonin causally upstream of aggression.","evidence":"Transgene-insertion knockout mouse with neurochemical quantitation and pharmacological rescue by parachlorophenylalanine","pmids":["7792602"],"confidence":"High","gaps":["Knockout generated by transgene integration rather than clean targeted deletion","Human relevance of behavioral phenotype not addressed"]},{"year":1999,"claim":"Side-by-side comparison of MAO-A and MAO-B knockouts resolved the distinct substrate selectivities and behavioral roles of the two isoenzymes.","evidence":"MAO-A and MAO-B knockout mice with brain monoamine measurement and behavioral assays","pmids":["10591056"],"confidence":"High","gaps":["Did not define structural basis of substrate discrimination"]},{"year":1996,"claim":"Mutational scanning answered whether normal variation in MAO-A activity arises from coding changes, showing it does not and pointing to regulatory variation.","evidence":"SSCP/sequencing of MAOA coding sequence correlated with fibroblast enzyme activity in 40 males","pmids":["8678123"],"confidence":"Medium","gaps":["Single cohort; did not identify the regulatory element responsible","Activity measured only in fibroblasts"]},{"year":2019,"claim":"Meta-analysis confirmed the 5' VNTR as a functional promoter polymorphism that sets MAO-A activity, anchoring the regulatory-variation hypothesis.","evidence":"Systematic review/meta-analysis of 255 studies of polymorphism effects on enzyme activity","pmids":["31303260"],"confidence":"High","gaps":["Mechanism by which VNTR copy number alters transcription not dissected here"]},{"year":2009,"claim":"Allele-specific expression and methylation analyses settled whether MAOA escapes X-inactivation, establishing monoallelic expression and an epigenetic regulatory layer.","evidence":"Allele-specific expression and 5' DNA methylation analysis in skewed-XCI human fibroblasts (with prior clonal RFLP analysis)","pmids":["19684479","16890910"],"confidence":"Medium","gaps":["Single tissue type (fibroblasts)","Does not address tissue-specific escape in brain"]},{"year":2018,"claim":"Reporter assays directly demonstrated that promoter methylation functionally represses MAOA transcription, linking epigenetic state to enzyme output.","evidence":"Luciferase reporter assay comparing methylated and unmethylated MAOA promoter constructs","pmids":["30169842"],"confidence":"Medium","gaps":["Single in vitro method","Does not identify the methyltransferases or signals controlling promoter methylation in vivo"]},{"year":2012,"claim":"Combined human PET imaging and cell-based assays established that glucocorticoid signaling acutely downregulates MAO-A density and activity, connecting stress physiology to enzyme regulation.","evidence":"[11C]harmine PET in stressed humans plus dexamethasone treatment with Western blot and 5-HT metabolism assay in neuronal/glial lines","pmids":["23197705"],"confidence":"High","gaps":["Transcriptional versus post-translational mechanism of acute downregulation not fully resolved"]},{"year":2018,"claim":"Dissection of cytokine signaling defined an IL-13→STAT6→15-LO→PPARγ axis and a panel of transcription factors (STAT1/3/6, EGR1, CREB) controlling MAO-A expression and activity in monocytes and lung cells.","evidence":"siRNA knockdowns of transcription factors and 15-LO with MAO-A activity, ROS, and migration assays in primary monocytes and A549 cells","pmids":["30021838"],"confidence":"High","gaps":["Generalizability of this axis beyond monocytes/A549 not established"]},{"year":2017,"claim":"Identification of REST as a direct MAOA regulator and of ROS-driven autophagy/apoptosis effects linked MAOA transcriptional control to neuroendocrine prostate cancer phenotypes.","evidence":"Reporter assays, siRNA knockdown, MAOA inhibitor treatment with ROS, apoptosis and autophagy readouts","pmids":["28402333"],"confidence":"Medium","gaps":["Single lab, in vitro only","Direct REST binding shown by reporter rather than endogenous occupancy"]},{"year":2018,"claim":"A Pten/MAOA double-knockout model and knockdowns established that MAOA promotes prostate tumor growth and cancer stem-cell maintenance through PTEN/AKT signaling.","evidence":"Conditional prostate-specific double KO mouse, shRNA/siRNA knockdown, spheroid and colony assays, IHC for stemness markers","pmids":["29844571"],"confidence":"High","gaps":["Whether enzymatic ROS production is strictly required for the AKT effect not isolated"]},{"year":2021,"claim":"Mechanistic studies built out the prostate cancer signaling network, defining MAOA-driven perineural invasion via Twist1→SEMA3C→PlexinA2/NRP1→cMET and a positive feedback loop with the androgen receptor through an intronic ARE and Shh/Gli-YAP1.","evidence":"ChIP, reporter assays, in vitro PNI assays, orthotopic and CRPC xenograft models with MAOA inhibitor and silencing","pmids":["33420365","34167949"],"confidence":"High","gaps":["Relative contribution of enzymatic ROS versus non-catalytic functions to these transcriptional outputs not separated"]},{"year":2020,"claim":"Stromal studies showed MAOA in fibroblasts drives prostate tumorigenesis by ROS-induced, Twist1-dependent IL-6 transcription feeding paracrine IL-6/STAT3 activation of CD44 in cancer cells.","evidence":"Co-culture, in vivo tumor models, ChIP of Twist1 at the IL-6 promoter E-box, tissue microarray","pmids":["32066880"],"confidence":"High","gaps":["How MAO-A-derived ROS leads to Twist1 activation upstream of IL-6 not detailed"]},{"year":2025,"claim":"Single-cell and co-culture work extended the stromal role, showing that inhibiting stromal MAOA raises WNT5A to activate CD8+ T-cell cytotoxicity via Ca2+-NFATC1 and relieve immunosuppression.","evidence":"Single-cell re-analysis, stromal-immune co-culture, syngeneic and humanized mouse tumor models with MAOA inhibitor","pmids":["40121032"],"confidence":"Medium","gaps":["Single lab","Direct molecular link from MAOA loss to WNT5A induction not fully mapped"]},{"year":2023,"claim":"Work in breast and gastric cancers revealed context-dependent tumor-suppressive roles, with MAO-A restrained downstream of IL-6R in hypoxic breast cancer and binding NDRG1 to suppress glycolysis via PI3K/AKT/mTOR in gastric cancer.","evidence":"IL-6R siRNA and 5-azacytidine in breast models; Co-IP, Seahorse, and in vivo gastric cancer models","pmids":["29695771","37249744"],"confidence":"Medium","gaps":["Opposing pro- versus anti-tumor roles across tissues not mechanistically reconciled","MAOA-NDRG1 interaction from single-lab Co-IP without reciprocal structural validation"]},{"year":2024,"claim":"Non-malignant disease studies tied MAO-A-derived oxidative stress to pathology: pulmonary vascular remodeling in PAH, PI3K/AKT-dependent senescence in trabecular meshwork cells, and ROS/NFκB-dependent placental tryptophan metabolism disruption.","evidence":"SuHx and banding rat PAH models with clorgyline; PI3K inhibitor and PIK3R1 silencing in trabecular meshwork plus GIG mouse model; TPhP exposure with clorgyline in trophoblasts and placenta","pmids":["33264068","39688282","37659542"],"confidence":"Medium","gaps":["Each established in a single lab/model","Causal sufficiency of MAO-A ROS versus correlation not fully isolated"]},{"year":null,"claim":"It remains unresolved how much of MAOA's oncogenic and pathological signaling depends on its catalytic ROS generation versus non-enzymatic scaffolding functions, and what reconciles its opposing pro- and anti-tumor roles across tissues.","evidence":"","pmids":[],"confidence":"Medium","gaps":["No catalytically-dead mutant rescue separating ROS-dependent from independent functions","No unifying model for tissue-specific tumor-promoting versus tumor-suppressing behavior"]}],"mechanism_profile":{"molecular_activity":[{"term_id":"GO:0016491","term_label":"oxidoreductase activity","supporting_discovery_ids":[0,1,2,4]},{"term_id":"GO:0016787","term_label":"hydrolase activity","supporting_discovery_ids":[0,1,2]}],"localization":[{"term_id":"GO:0005739","term_label":"mitochondrion","supporting_discovery_ids":[2]}],"pathway":[{"term_id":"R-HSA-112316","term_label":"Neuronal System","supporting_discovery_ids":[0,1]},{"term_id":"R-HSA-1430728","term_label":"Metabolism","supporting_discovery_ids":[1,2,18]},{"term_id":"R-HSA-162582","term_label":"Signal Transduction","supporting_discovery_ids":[6,7,8,9,10]},{"term_id":"R-HSA-1643685","term_label":"Disease","supporting_discovery_ids":[19,20,22]},{"term_id":"R-HSA-168256","term_label":"Immune System","supporting_discovery_ids":[21,13]}],"complexes":[],"partners":["NDRG1","TWIST1","AR"],"other_free_text":[]}},"prefetch_data":{"uniprot":{"accession":"P21397","full_name":"Amine oxidase [flavin-containing] A","aliases":["Monoamine oxidase type A","MAO-A"],"length_aa":527,"mass_kda":59.7,"function":"Catalyzes the oxidative deamination of primary and some secondary amine such as neurotransmitters, with concomitant reduction of oxygen to hydrogen peroxide and has important functions in the metabolism of neuroactive and vasoactive amines in the central nervous system and peripheral tissues (PubMed:18391214, PubMed:20493079, PubMed:24169519, PubMed:8316221). Preferentially oxidizes serotonin (PubMed:20493079, PubMed:24169519). Also catalyzes the oxidative deamination of kynuramine to 3-(2-aminophenyl)-3-oxopropanal that can spontaneously condense to 4-hydroxyquinoline (By similarity)","subcellular_location":"Mitochondrion outer membrane","url":"https://www.uniprot.org/uniprotkb/P21397/entry"},"depmap":{"release":"DepMap","has_data":true,"is_common_essential":false,"resolved_as":"","url":"https://depmap.org/portal/gene/MAOA","classification":"Not Classified","n_dependent_lines":1,"n_total_lines":1208,"dependency_fraction":0.0008278145695364238},"opencell":{"profiled":false,"resolved_as":"","ensg_id":"","cell_line_id":"","localizations":[],"interactors":[],"url":"https://opencell.sf.czbiohub.org/search/MAOA","total_profiled":1310},"omim":[{"mim_id":"609685","title":"CELL DIVISION CYCLE-ASSOCIATED PROTEIN 7-LIKE; CDCA7L","url":"https://www.omim.org/entry/609685"},{"mim_id":"609312","title":"DOPAMINE BETA-HYDROXYLASE, PLASMA; DBH","url":"https://www.omim.org/entry/609312"},{"mim_id":"606788","title":"ANOREXIA NERVOSA, SUSCEPTIBILITY TO; ANON","url":"https://www.omim.org/entry/606788"},{"mim_id":"606416","title":"NLR FAMILY, PYRIN DOMAIN-CONTAINING 3; NLRP3","url":"https://www.omim.org/entry/606416"},{"mim_id":"604479","title":"SIRTUIN 1; SIRT1","url":"https://www.omim.org/entry/604479"}],"hpa":{"profiled":true,"resolved_as":"","reliability":"Supported","locations":[{"location":"Mitochondria","reliability":"Supported"},{"location":"Cytosol","reliability":"Additional"}],"tissue_specificity":"Tissue enhanced","tissue_distribution":"Detected in many","driving_tissues":[{"tissue":"intestine","ntpm":206.3}],"url":"https://www.proteinatlas.org/search/MAOA"},"hgnc":{"alias_symbol":[],"prev_symbol":[]},"alphafold":{"accession":"P21397","domains":[{"cath_id":"3.50.50.60","chopping":"12-58_67-86_218-298_410-469","consensus_level":"high","plddt":98.5112,"start":12,"end":469},{"cath_id":"3.90.660.10","chopping":"112-209_489-519","consensus_level":"medium","plddt":98.0202,"start":112,"end":519},{"cath_id":"3.90.660.10","chopping":"303-396","consensus_level":"medium","plddt":98.349,"start":303,"end":396}],"viewer_url":"https://alphafold.ebi.ac.uk/entry/P21397","model_url":"https://alphafold.ebi.ac.uk/files/AF-P21397-F1-model_v6.cif","pae_url":"https://alphafold.ebi.ac.uk/files/AF-P21397-F1-predicted_aligned_error_v6.png","plddt_mean":97.0},"mouse_models":{"mgi_url":"https://www.informatics.jax.org/marker/summary?nomen=MAOA","jax_strain_url":"https://www.jax.org/strain/search?query=MAOA"},"sequence":{"accession":"P21397","fasta_url":"https://rest.uniprot.org/uniprotkb/P21397.fasta","uniprot_url":"https://www.uniprot.org/uniprotkb/P21397/entry","alphafold_viewer_url":"https://alphafold.ebi.ac.uk/entry/P21397"}},"corpus_meta":[{"pmid":"7792602","id":"PMC_7792602","title":"Aggressive behavior and altered amounts of brain serotonin and norepinephrine in mice lacking MAOA.","date":"1995","source":"Science (New York, N.Y.)","url":"https://pubmed.ncbi.nlm.nih.gov/7792602","citation_count":876,"is_preprint":false},{"pmid":"16801953","id":"PMC_16801953","title":"MAOA, maltreatment, and gene-environment interaction predicting children's mental health: new evidence and a meta-analysis.","date":"2006","source":"Molecular psychiatry","url":"https://pubmed.ncbi.nlm.nih.gov/16801953","citation_count":593,"is_preprint":false},{"pmid":"27803666","id":"PMC_27803666","title":"Inhibitors of MAO-A and MAO-B in Psychiatry and Neurology.","date":"2016","source":"Frontiers in pharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/27803666","citation_count":300,"is_preprint":false},{"pmid":"18258310","id":"PMC_18258310","title":"MAOA and the neurogenetic architecture of human aggression.","date":"2008","source":"Trends in neurosciences","url":"https://pubmed.ncbi.nlm.nih.gov/18258310","citation_count":203,"is_preprint":false},{"pmid":"16814261","id":"PMC_16814261","title":"MAOA and the \"cycle of violence:\" childhood abuse and neglect, MAOA genotype, and risk for violent and antisocial behavior.","date":"2006","source":"Biological psychiatry","url":"https://pubmed.ncbi.nlm.nih.gov/16814261","citation_count":198,"is_preprint":false},{"pmid":"23786983","id":"PMC_23786983","title":"MAOA, childhood maltreatment, and antisocial behavior: meta-analysis of a gene-environment interaction.","date":"2013","source":"Biological psychiatry","url":"https://pubmed.ncbi.nlm.nih.gov/23786983","citation_count":195,"is_preprint":false},{"pmid":"19168625","id":"PMC_19168625","title":"Monoamine oxidase A gene (MAOA) predicts behavioral aggression following provocation.","date":"2009","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/19168625","citation_count":172,"is_preprint":false},{"pmid":"23449091","id":"PMC_23449091","title":"Genetic and epigenetic associations of MAOA and NR3C1 with depression and childhood adversities.","date":"2013","source":"The international journal of neuropsychopharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/23449091","citation_count":168,"is_preprint":false},{"pmid":"17592478","id":"PMC_17592478","title":"Interaction between a functional MAOA locus and childhood sexual abuse predicts alcoholism and antisocial personality disorder in adult women.","date":"2007","source":"Molecular psychiatry","url":"https://pubmed.ncbi.nlm.nih.gov/17592478","citation_count":152,"is_preprint":false},{"pmid":"27045843","id":"PMC_27045843","title":"MAOA gene hypomethylation in panic disorder-reversibility of an epigenetic risk pattern by psychotherapy.","date":"2016","source":"Translational psychiatry","url":"https://pubmed.ncbi.nlm.nih.gov/27045843","citation_count":120,"is_preprint":false},{"pmid":"26499200","id":"PMC_26499200","title":"Curcumin inhibits cancer-associated fibroblast-driven prostate cancer invasion through MAOA/mTOR/HIF-1α signaling.","date":"2015","source":"International journal of oncology","url":"https://pubmed.ncbi.nlm.nih.gov/26499200","citation_count":105,"is_preprint":false},{"pmid":"17034017","id":"PMC_17034017","title":"Adolescent girls and criminal activity: role of MAOA-LPR genotype and psychosocial factors.","date":"2007","source":"American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics","url":"https://pubmed.ncbi.nlm.nih.gov/17034017","citation_count":95,"is_preprint":false},{"pmid":"12815746","id":"PMC_12815746","title":"Association analysis of MAOA and COMT with neuroticism assessed by peers.","date":"2003","source":"American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics","url":"https://pubmed.ncbi.nlm.nih.gov/12815746","citation_count":94,"is_preprint":false},{"pmid":"24902785","id":"PMC_24902785","title":"Candidate genes for aggression and antisocial behavior: a meta-analysis of association studies of the 5HTTLPR and MAOA-uVNTR.","date":"2014","source":"Behavior genetics","url":"https://pubmed.ncbi.nlm.nih.gov/24902785","citation_count":90,"is_preprint":false},{"pmid":"19255579","id":"PMC_19255579","title":"Interaction of prenatal exposure to cigarettes and MAOA genotype in pathways to youth antisocial behavior.","date":"2009","source":"Molecular psychiatry","url":"https://pubmed.ncbi.nlm.nih.gov/19255579","citation_count":90,"is_preprint":false},{"pmid":"20734127","id":"PMC_20734127","title":"Maltreatment, MAOA, and delinquency: sex differences in gene-environment interaction in a large population-based cohort of adolescents.","date":"2010","source":"Behavior genetics","url":"https://pubmed.ncbi.nlm.nih.gov/20734127","citation_count":84,"is_preprint":false},{"pmid":"19804559","id":"PMC_19804559","title":"Early life stress, MAOA, and gene-environment interactions predict behavioral disinhibition in children.","date":"2009","source":"Genes, brain, and behavior","url":"https://pubmed.ncbi.nlm.nih.gov/19804559","citation_count":83,"is_preprint":false},{"pmid":"33420365","id":"PMC_33420365","title":"MAOA promotes prostate cancer cell perineural invasion through SEMA3C/PlexinA2/NRP1-cMET signaling.","date":"2021","source":"Oncogene","url":"https://pubmed.ncbi.nlm.nih.gov/33420365","citation_count":76,"is_preprint":false},{"pmid":"23319006","id":"PMC_23319006","title":"MAOA and mechanisms of panic disorder revisited: from bench to molecular psychotherapy.","date":"2013","source":"Molecular psychiatry","url":"https://pubmed.ncbi.nlm.nih.gov/23319006","citation_count":74,"is_preprint":false},{"pmid":"2906043","id":"PMC_2906043","title":"Human monoamine oxidase gene (MAOA): chromosome position (Xp21-p11) and DNA polymorphism.","date":"1988","source":"Genomics","url":"https://pubmed.ncbi.nlm.nih.gov/2906043","citation_count":74,"is_preprint":false},{"pmid":"11443519","id":"PMC_11443519","title":"MAO-A and COMT polymorphisms and gene effects in narcolepsy.","date":"2001","source":"Molecular psychiatry","url":"https://pubmed.ncbi.nlm.nih.gov/11443519","citation_count":73,"is_preprint":false},{"pmid":"21628708","id":"PMC_21628708","title":"MAOA, abuse exposure and antisocial behaviour: 30-year longitudinal study.","date":"2011","source":"The British journal of psychiatry : the journal of mental science","url":"https://pubmed.ncbi.nlm.nih.gov/21628708","citation_count":73,"is_preprint":false},{"pmid":"31303260","id":"PMC_31303260","title":"Which Dopamine Polymorphisms Are Functional? Systematic Review and Meta-analysis of COMT, DAT, DBH, DDC, DRD1-5, MAOA, MAOB, TH, VMAT1, and VMAT2.","date":"2019","source":"Biological psychiatry","url":"https://pubmed.ncbi.nlm.nih.gov/31303260","citation_count":71,"is_preprint":false},{"pmid":"10402508","id":"PMC_10402508","title":"Analysis of the monoamine oxidase A (MAOA) gene in bipolar affective disorder by association studies, meta-analyses, and sequencing of the promoter.","date":"1999","source":"American journal of medical genetics","url":"https://pubmed.ncbi.nlm.nih.gov/10402508","citation_count":69,"is_preprint":false},{"pmid":"12116182","id":"PMC_12116182","title":"Schizophrenia and functional polymorphisms in the MAOA and COMT genes: no evidence for association or epistasis.","date":"2002","source":"American journal of medical genetics","url":"https://pubmed.ncbi.nlm.nih.gov/12116182","citation_count":64,"is_preprint":false},{"pmid":"10591056","id":"PMC_10591056","title":"MAO-A and -B gene knock-out mice exhibit distinctly different behavior.","date":"1999","source":"Neurobiology (Budapest, Hungary)","url":"https://pubmed.ncbi.nlm.nih.gov/10591056","citation_count":58,"is_preprint":false},{"pmid":"30693539","id":"PMC_30693539","title":"Effect of Monoamine oxidase A (MAOA) inhibitors on androgen-sensitive and castration-resistant prostate cancer cells.","date":"2019","source":"The Prostate","url":"https://pubmed.ncbi.nlm.nih.gov/30693539","citation_count":54,"is_preprint":false},{"pmid":"16770335","id":"PMC_16770335","title":"A functional polymorphism in the MAOA gene promoter (MAOA-LPR) predicts central dopamine function and body mass index.","date":"2006","source":"Molecular psychiatry","url":"https://pubmed.ncbi.nlm.nih.gov/16770335","citation_count":54,"is_preprint":false},{"pmid":"29844571","id":"PMC_29844571","title":"Loss of MAOA in epithelia inhibits adenocarcinoma development, cell proliferation and cancer stem cells in prostate.","date":"2018","source":"Oncogene","url":"https://pubmed.ncbi.nlm.nih.gov/29844571","citation_count":53,"is_preprint":false},{"pmid":"22297589","id":"PMC_22297589","title":"Moderating role of the MAOA genotype in antisocial behaviour.","date":"2012","source":"The British journal of psychiatry : the journal of mental science","url":"https://pubmed.ncbi.nlm.nih.gov/22297589","citation_count":53,"is_preprint":false},{"pmid":"10673777","id":"PMC_10673777","title":"Pathological gambling and DNA polymorphic markers at MAO-A and MAO-B genes.","date":"2000","source":"Molecular psychiatry","url":"https://pubmed.ncbi.nlm.nih.gov/10673777","citation_count":51,"is_preprint":false},{"pmid":"28402333","id":"PMC_28402333","title":"MAOA-a novel decision maker of apoptosis and autophagy in hormone refractory neuroendocrine prostate cancer cells.","date":"2017","source":"Scientific reports","url":"https://pubmed.ncbi.nlm.nih.gov/28402333","citation_count":49,"is_preprint":false},{"pmid":"30242487","id":"PMC_30242487","title":"Epigenetic signature of MAOA and MAOB genes in mental disorders.","date":"2018","source":"Journal of neural transmission (Vienna, Austria : 1996)","url":"https://pubmed.ncbi.nlm.nih.gov/30242487","citation_count":48,"is_preprint":false},{"pmid":"23067570","id":"PMC_23067570","title":"MAOA genotype, social exclusion and aggression: an experimental test of a gene-environment interaction.","date":"2012","source":"Genes, brain, and behavior","url":"https://pubmed.ncbi.nlm.nih.gov/23067570","citation_count":48,"is_preprint":false},{"pmid":"22911667","id":"PMC_22911667","title":"Meta-analysis argues for a female-specific role of MAOA-uVNTR in panic disorder in four European populations.","date":"2012","source":"American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics","url":"https://pubmed.ncbi.nlm.nih.gov/22911667","citation_count":46,"is_preprint":false},{"pmid":"18075472","id":"PMC_18075472","title":"The MAOA promoter polymorphism, disruptive behavior disorders, and early onset substance use disorder: gene-environment interaction.","date":"2007","source":"Psychiatric genetics","url":"https://pubmed.ncbi.nlm.nih.gov/18075472","citation_count":44,"is_preprint":false},{"pmid":"23170243","id":"PMC_23170243","title":"The effects of MAOA genotype, childhood trauma, and sex on trait and state-dependent aggression.","date":"2012","source":"Brain and behavior","url":"https://pubmed.ncbi.nlm.nih.gov/23170243","citation_count":44,"is_preprint":false},{"pmid":"22030358","id":"PMC_22030358","title":"Child abuse and neglect, MAOA, and mental health outcomes: a prospective examination.","date":"2011","source":"Biological psychiatry","url":"https://pubmed.ncbi.nlm.nih.gov/22030358","citation_count":43,"is_preprint":false},{"pmid":"29695771","id":"PMC_29695771","title":"Differential expression of IL-6/IL-6R and MAO-A regulates invasion/angiogenesis in breast cancer.","date":"2018","source":"British journal of cancer","url":"https://pubmed.ncbi.nlm.nih.gov/29695771","citation_count":43,"is_preprint":false},{"pmid":"16856146","id":"PMC_16856146","title":"MAOA promoter polymorphism and attention deficit hyperactivity disorder (ADHD) in indian children.","date":"2006","source":"American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics","url":"https://pubmed.ncbi.nlm.nih.gov/16856146","citation_count":43,"is_preprint":false},{"pmid":"1556068","id":"PMC_1556068","title":"A monoamine-regulated Klebsiella aerogenes operon containing the monoamine oxidase structural gene (maoA) and the maoC gene.","date":"1992","source":"Journal of bacteriology","url":"https://pubmed.ncbi.nlm.nih.gov/1556068","citation_count":43,"is_preprint":false},{"pmid":"32066880","id":"PMC_32066880","title":"MAOA-mediated reprogramming of stromal fibroblasts promotes prostate tumorigenesis and cancer stemness.","date":"2020","source":"Oncogene","url":"https://pubmed.ncbi.nlm.nih.gov/32066880","citation_count":42,"is_preprint":false},{"pmid":"19357553","id":"PMC_19357553","title":"Parental care moderates the influence of MAOA-uVNTR genotype and childhood stressors on trait impulsivity and aggression in adult women.","date":"2009","source":"Psychiatric genetics","url":"https://pubmed.ncbi.nlm.nih.gov/19357553","citation_count":42,"is_preprint":false},{"pmid":"23726513","id":"PMC_23726513","title":"MAOA genotype, childhood maltreatment, and their interaction in the etiology of adult antisocial behaviors.","date":"2013","source":"Biological psychiatry","url":"https://pubmed.ncbi.nlm.nih.gov/23726513","citation_count":40,"is_preprint":false},{"pmid":"22198720","id":"PMC_22198720","title":"Effects of MAOA promoter methylation on susceptibility to paranoid schizophrenia.","date":"2011","source":"Human genetics","url":"https://pubmed.ncbi.nlm.nih.gov/22198720","citation_count":38,"is_preprint":false},{"pmid":"19120058","id":"PMC_19120058","title":"Effects of MAOA-genotype, alcohol consumption, and aging on violent behavior.","date":"2008","source":"Alcoholism, clinical and experimental research","url":"https://pubmed.ncbi.nlm.nih.gov/19120058","citation_count":37,"is_preprint":false},{"pmid":"37249744","id":"PMC_37249744","title":"MAOA suppresses the growth of gastric cancer by interacting with NDRG1 and regulating the Warburg effect through the PI3K/AKT/mTOR pathway.","date":"2023","source":"Cellular oncology (Dordrecht, Netherlands)","url":"https://pubmed.ncbi.nlm.nih.gov/37249744","citation_count":36,"is_preprint":false},{"pmid":"8862875","id":"PMC_8862875","title":"MAOA deficiency and abnormal behaviour: perspectives on an association.","date":"1996","source":"Ciba Foundation symposium","url":"https://pubmed.ncbi.nlm.nih.gov/8862875","citation_count":35,"is_preprint":false},{"pmid":"25082653","id":"PMC_25082653","title":"Association of low-activity MAOA allelic variants with violent crime in incarcerated offenders.","date":"2014","source":"Journal of psychiatric research","url":"https://pubmed.ncbi.nlm.nih.gov/25082653","citation_count":35,"is_preprint":false},{"pmid":"26620113","id":"PMC_26620113","title":"The MAOA, COMT, MTHFR and ESR1 gene polymorphisms are associated with the risk of depression in menopausal women.","date":"2015","source":"Maturitas","url":"https://pubmed.ncbi.nlm.nih.gov/26620113","citation_count":34,"is_preprint":false},{"pmid":"30169842","id":"PMC_30169842","title":"Plasticity of Functional MAOA Gene Methylation in Acrophobia.","date":"2018","source":"The international journal of neuropsychopharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/30169842","citation_count":33,"is_preprint":false},{"pmid":"18726986","id":"PMC_18726986","title":"Differential association between MAOA, ADHD and neuropsychological functioning in boys and girls.","date":"2008","source":"American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics","url":"https://pubmed.ncbi.nlm.nih.gov/18726986","citation_count":33,"is_preprint":false},{"pmid":"25522433","id":"PMC_25522433","title":"Genotypes do not confer risk for delinquency but rather alter susceptibility to positive and negative environmental factors: gene-environmentinteractions of BDNF Val66Met, 5-HTTLPR, and MAOA-uVNTR [corrected].","date":"2014","source":"The international journal of neuropsychopharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/25522433","citation_count":33,"is_preprint":false},{"pmid":"15936529","id":"PMC_15936529","title":"Gene-gene interaction between MAOA and COMT in suicidal behavior.","date":"2005","source":"Neuroscience letters","url":"https://pubmed.ncbi.nlm.nih.gov/15936529","citation_count":32,"is_preprint":false},{"pmid":"26932718","id":"PMC_26932718","title":"Monoamine Oxidase A (MAOA) and Catechol-O-Methyltransferase (COMT) Gene Polymorphisms Interact with Maternal Parenting in Association with Adolescent Reactive Aggression but not Proactive Aggression: Evidence of Differential Susceptibility.","date":"2016","source":"Journal of youth and adolescence","url":"https://pubmed.ncbi.nlm.nih.gov/26932718","citation_count":32,"is_preprint":false},{"pmid":"26148813","id":"PMC_26148813","title":"MAOA expression predicts vulnerability for alcohol use.","date":"2015","source":"Molecular psychiatry","url":"https://pubmed.ncbi.nlm.nih.gov/26148813","citation_count":31,"is_preprint":false},{"pmid":"26227907","id":"PMC_26227907","title":"MAOA Variants and Genetic Susceptibility to Major Psychiatric Disorders.","date":"2015","source":"Molecular neurobiology","url":"https://pubmed.ncbi.nlm.nih.gov/26227907","citation_count":31,"is_preprint":false},{"pmid":"22225631","id":"PMC_22225631","title":"Apolipoprotein E influences melatonin biosynthesis by regulating NAT and MAOA expression in C6 cells.","date":"2012","source":"Journal of pineal research","url":"https://pubmed.ncbi.nlm.nih.gov/22225631","citation_count":31,"is_preprint":false},{"pmid":"23111930","id":"PMC_23111930","title":"MAOA and MAOB polymorphisms and anger-related traits in suicidal participants and controls.","date":"2012","source":"European archives of psychiatry and clinical neuroscience","url":"https://pubmed.ncbi.nlm.nih.gov/23111930","citation_count":30,"is_preprint":false},{"pmid":"37076041","id":"PMC_37076041","title":"Monoamine oxidase A (MAOA): A promising target for prostate cancer therapy.","date":"2023","source":"Cancer letters","url":"https://pubmed.ncbi.nlm.nih.gov/37076041","citation_count":29,"is_preprint":false},{"pmid":"16725119","id":"PMC_16725119","title":"Gene-gene interaction between MAOA and COMT in suicidal behavior: analysis in schizophrenia.","date":"2006","source":"Brain research","url":"https://pubmed.ncbi.nlm.nih.gov/16725119","citation_count":29,"is_preprint":false},{"pmid":"32499684","id":"PMC_32499684","title":"The MAOA Gene Influences the Neural Response to Psychosocial Stress in the Human Brain.","date":"2020","source":"Frontiers in behavioral neuroscience","url":"https://pubmed.ncbi.nlm.nih.gov/32499684","citation_count":29,"is_preprint":false},{"pmid":"16110245","id":"PMC_16110245","title":"Association study of a functional MAOA-uVNTR gene polymorphism and personality traits in Chinese young females.","date":"2005","source":"Neuropsychobiology","url":"https://pubmed.ncbi.nlm.nih.gov/16110245","citation_count":29,"is_preprint":false},{"pmid":"19382113","id":"PMC_19382113","title":"MAOA gene polymorphisms and response to mirtazapine in major depression.","date":"2009","source":"Human psychopharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/19382113","citation_count":28,"is_preprint":false},{"pmid":"22193458","id":"PMC_22193458","title":"MAOA, MTHFR, and TNF-β genes polymorphisms and personality traits in the pathogenesis of migraine.","date":"2011","source":"Molecular and cellular biochemistry","url":"https://pubmed.ncbi.nlm.nih.gov/22193458","citation_count":27,"is_preprint":false},{"pmid":"30021838","id":"PMC_30021838","title":"Regulation of monoamine oxidase A (MAO-A) expression, activity, and function in IL-13-stimulated monocytes and A549 lung carcinoma cells.","date":"2018","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/30021838","citation_count":27,"is_preprint":false},{"pmid":"23197705","id":"PMC_23197705","title":"Convergent effects of acute stress and glucocorticoid exposure upon MAO-A in humans.","date":"2012","source":"The Journal of neuroscience : the official journal of the Society for Neuroscience","url":"https://pubmed.ncbi.nlm.nih.gov/23197705","citation_count":27,"is_preprint":false},{"pmid":"21530215","id":"PMC_21530215","title":"Association of MAOA and COMT gene polymorphisms with palatable food intake in children.","date":"2011","source":"The Journal of nutritional biochemistry","url":"https://pubmed.ncbi.nlm.nih.gov/21530215","citation_count":26,"is_preprint":false},{"pmid":"19214141","id":"PMC_19214141","title":"Association of MAOA gene functional promoter polymorphism with CSF dopamine turnover and atypical depression.","date":"2009","source":"Pharmacogenetics and genomics","url":"https://pubmed.ncbi.nlm.nih.gov/19214141","citation_count":26,"is_preprint":false},{"pmid":"32931665","id":"PMC_32931665","title":"The clinical value and potential molecular mechanism of the downregulation of MAOA in hepatocellular carcinoma tissues.","date":"2020","source":"Cancer medicine","url":"https://pubmed.ncbi.nlm.nih.gov/32931665","citation_count":25,"is_preprint":false},{"pmid":"17944904","id":"PMC_17944904","title":"Bad nature, bad nurture, and testimony regarding MAOA and SLC6A4 genotyping at murder trials.","date":"2007","source":"Journal of forensic sciences","url":"https://pubmed.ncbi.nlm.nih.gov/17944904","citation_count":25,"is_preprint":false},{"pmid":"24326626","id":"PMC_24326626","title":"The 2-repeat allele of the MAOA gene confers an increased risk for shooting and stabbing behaviors.","date":"2014","source":"The Psychiatric quarterly","url":"https://pubmed.ncbi.nlm.nih.gov/24326626","citation_count":23,"is_preprint":false},{"pmid":"26494873","id":"PMC_26494873","title":"Effects of the MAOA gene and levels of exposure to violence on antisocial outcomes.","date":"2015","source":"The British journal of psychiatry : the journal of mental science","url":"https://pubmed.ncbi.nlm.nih.gov/26494873","citation_count":23,"is_preprint":false},{"pmid":"8678123","id":"PMC_8678123","title":"Mutational analysis of the human MAOA gene.","date":"1996","source":"American journal of medical genetics","url":"https://pubmed.ncbi.nlm.nih.gov/8678123","citation_count":23,"is_preprint":false},{"pmid":"34167949","id":"PMC_34167949","title":"Bidirectional Cross-talk between MAOA and AR Promotes Hormone-Dependent and Castration-Resistant Prostate Cancer.","date":"2021","source":"Cancer research","url":"https://pubmed.ncbi.nlm.nih.gov/34167949","citation_count":22,"is_preprint":false},{"pmid":"29952131","id":"PMC_29952131","title":"Tobacco and cannabis use in college students are predicted by sex-dimorphic interactions between MAOA genotype and child abuse.","date":"2018","source":"CNS neuroscience & therapeutics","url":"https://pubmed.ncbi.nlm.nih.gov/29952131","citation_count":22,"is_preprint":false},{"pmid":"26481676","id":"PMC_26481676","title":"MAOA-VNTR polymorphism modulates context-dependent dopamine release and aggressive behavior in males.","date":"2015","source":"NeuroImage","url":"https://pubmed.ncbi.nlm.nih.gov/26481676","citation_count":22,"is_preprint":false},{"pmid":"22138326","id":"PMC_22138326","title":"The association of 5-HTR2A-1438A/G, COMTVal158Met, MAOA-LPR, DATVNTR and 5-HTTVNTR gene polymorphisms and antisocial personality disorder in male heroin-dependent Chinese subjects.","date":"2011","source":"Progress in neuro-psychopharmacology & biological psychiatry","url":"https://pubmed.ncbi.nlm.nih.gov/22138326","citation_count":22,"is_preprint":false},{"pmid":"29478144","id":"PMC_29478144","title":"Integration of transcriptomic and cytoarchitectonic data implicates a role for MAOA and TAC1 in the limbic-cortical network.","date":"2018","source":"Brain structure & function","url":"https://pubmed.ncbi.nlm.nih.gov/29478144","citation_count":21,"is_preprint":false},{"pmid":"10050962","id":"PMC_10050962","title":"Screen for MAOA mutations in target human groups.","date":"1999","source":"American journal of medical genetics","url":"https://pubmed.ncbi.nlm.nih.gov/10050962","citation_count":21,"is_preprint":false},{"pmid":"10333983","id":"PMC_10333983","title":"Preclinical profile of befloxatone, a new reversible MAO-A inhibitor.","date":"1998","source":"Journal of affective disorders","url":"https://pubmed.ncbi.nlm.nih.gov/10333983","citation_count":21,"is_preprint":false},{"pmid":"31314763","id":"PMC_31314763","title":"Association of MAOA genetic variants and resilience with psychosocial stress: A longitudinal study of Syrian refugees.","date":"2019","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/31314763","citation_count":21,"is_preprint":false},{"pmid":"31448578","id":"PMC_31448578","title":"Emotional stability is associated with the MAOA promoter uVNTR polymorphism in women.","date":"2019","source":"Brain and behavior","url":"https://pubmed.ncbi.nlm.nih.gov/31448578","citation_count":20,"is_preprint":false},{"pmid":"16890910","id":"PMC_16890910","title":"Monoallelic expression of MAOA in skin fibroblasts.","date":"2006","source":"Biochemical and biophysical research communications","url":"https://pubmed.ncbi.nlm.nih.gov/16890910","citation_count":20,"is_preprint":false},{"pmid":"20477771","id":"PMC_20477771","title":"MAOA interacts with the ALDH2 gene in anxiety-depression alcohol dependence.","date":"2010","source":"Alcoholism, clinical and experimental research","url":"https://pubmed.ncbi.nlm.nih.gov/20477771","citation_count":20,"is_preprint":false},{"pmid":"33264068","id":"PMC_33264068","title":"Increased MAO-A Activity Promotes Progression of Pulmonary Arterial Hypertension.","date":"2021","source":"American journal of respiratory cell and molecular biology","url":"https://pubmed.ncbi.nlm.nih.gov/33264068","citation_count":19,"is_preprint":false},{"pmid":"19941049","id":"PMC_19941049","title":"Gene-gene interaction between COMT and MAOA potentially predicts the intelligence of attention-deficit hyperactivity disorder boys in China.","date":"2009","source":"Behavior genetics","url":"https://pubmed.ncbi.nlm.nih.gov/19941049","citation_count":19,"is_preprint":false},{"pmid":"17894408","id":"PMC_17894408","title":"Meta-study on association between the monoamine oxidase A gene (MAOA) and schizophrenia.","date":"2008","source":"American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics","url":"https://pubmed.ncbi.nlm.nih.gov/17894408","citation_count":19,"is_preprint":false},{"pmid":"27823806","id":"PMC_27823806","title":"The forensic use of behavioral genetics in criminal proceedings: Case of the MAOA-L genotype.","date":"2016","source":"International journal of law and psychiatry","url":"https://pubmed.ncbi.nlm.nih.gov/27823806","citation_count":19,"is_preprint":false},{"pmid":"27935229","id":"PMC_27935229","title":"Cortico-limbic connectivity in MAOA-L carriers is vulnerable to acute tryptophan depletion.","date":"2016","source":"Human brain mapping","url":"https://pubmed.ncbi.nlm.nih.gov/27935229","citation_count":18,"is_preprint":false},{"pmid":"29222910","id":"PMC_29222910","title":"Associations Between MAOA-uVNTR Genotype, Maltreatment, MAOA Methylation, and Alcohol Consumption in Young Adult Males.","date":"2018","source":"Alcoholism, clinical and experimental research","url":"https://pubmed.ncbi.nlm.nih.gov/29222910","citation_count":17,"is_preprint":false},{"pmid":"19684479","id":"PMC_19684479","title":"MAOA and GYG2 are submitted to X chromosome inactivation in human fibroblasts.","date":"2009","source":"Epigenetics","url":"https://pubmed.ncbi.nlm.nih.gov/19684479","citation_count":17,"is_preprint":false},{"pmid":"35566238","id":"PMC_35566238","title":"Design, Synthesis, and Biological Evaluation of Novel MAO-A Inhibitors Targeting Lung Cancer.","date":"2022","source":"Molecules (Basel, Switzerland)","url":"https://pubmed.ncbi.nlm.nih.gov/35566238","citation_count":17,"is_preprint":false},{"pmid":"30018578","id":"PMC_30018578","title":"Interacting Effect of Catechol-O-Methyltransferase (COMT) and Monoamine Oxidase A (MAOA) Gene Polymorphisms, and Stressful Life Events on Aggressive Behavior in Chinese Male Adolescents.","date":"2018","source":"Frontiers in psychology","url":"https://pubmed.ncbi.nlm.nih.gov/30018578","citation_count":17,"is_preprint":false},{"pmid":"39688282","id":"PMC_39688282","title":"Role of PI3K/AKT/MAOA in glucocorticoid-induced oxidative stress and associated premature senescence of the trabecular meshwork.","date":"2024","source":"Aging cell","url":"https://pubmed.ncbi.nlm.nih.gov/39688282","citation_count":16,"is_preprint":false},{"pmid":"30505241","id":"PMC_30505241","title":"Placental MAOA expression mediates prenatal stress effects on temperament in 12-month-olds.","date":"2018","source":"Infant and child development","url":"https://pubmed.ncbi.nlm.nih.gov/30505241","citation_count":16,"is_preprint":false},{"pmid":"19415821","id":"PMC_19415821","title":"Gene-gene interactions of CYP2A6 and MAOA polymorphisms on smoking behavior in Chinese male population.","date":"2009","source":"Pharmacogenetics and genomics","url":"https://pubmed.ncbi.nlm.nih.gov/19415821","citation_count":16,"is_preprint":false},{"pmid":"30414913","id":"PMC_30414913","title":"Early life stress and voluntary alcohol consumption in relation to Maoa methylation in male rats.","date":"2018","source":"Alcohol (Fayetteville, N.Y.)","url":"https://pubmed.ncbi.nlm.nih.gov/30414913","citation_count":15,"is_preprint":false},{"pmid":"40121032","id":"PMC_40121032","title":"Inhibition of stromal MAOA leading activation of WNT5A enhance prostate cancer immunotherapy by involving the transition of cancer-associated fibroblasts.","date":"2025","source":"Journal for immunotherapy of cancer","url":"https://pubmed.ncbi.nlm.nih.gov/40121032","citation_count":14,"is_preprint":false},{"pmid":"37659542","id":"PMC_37659542","title":"Triphenyl phosphate disrupts placental tryptophan metabolism by activating MAOA/ROS/NFκB.","date":"2023","source":"The Science of the total environment","url":"https://pubmed.ncbi.nlm.nih.gov/37659542","citation_count":14,"is_preprint":false}],"cost":{"stage1":{"model":"claude-sonnet-4-6","input_tokens":50630,"output_tokens":6501,"usd":0.124702,"stage1_stop_reason":"end_turn"},"stage2":{"model":"claude-opus-4-8","input_tokens":15759,"output_tokens":5235,"usd":0.104835,"stage2_stop_reason":"end_turn"},"total_usd":0.229537,"stage1_batch_id":"msgbatch_01BbTCMyrRPyhtEq6b1MdwCN","stage2_batch_id":"msgbatch_011dEed5bbxYvTAaQWKJevxu","note":"batch pricing = 50% of standard"},"stage1_raw":"```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 1995,\n      \"finding\": \"MAOA knockout mice (generated by transgene-insertion deletion) show up to ninefold elevation of brain serotonin and twofold elevation of norepinephrine in pup brains, demonstrating that MAOA is the primary enzyme responsible for degrading serotonin and norepinephrine in vivo. Loss of MAOA also causes cytoarchitectural changes in the somatosensory cortex and enhanced aggression in adult males; the behavioral alterations in pups were reversed by the serotonin synthesis inhibitor parachlorophenylalanine, placing elevated serotonin causally upstream of the behavioral phenotype.\",\n      \"method\": \"Transgenic knockout mouse (gene deletion via transgene integration), neurochemical quantitation, serotonin-like immunohistochemistry, pharmacological rescue with parachlorophenylalanine\",\n      \"journal\": \"Science\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 / Strong — in vivo genetic knockout with neurochemical quantitation, pharmacological rescue, and histological validation; highly cited foundational study replicated across multiple labs\",\n      \"pmids\": [\"7792602\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1999,\n      \"finding\": \"MAO-A preferentially oxidizes serotonin (5-HT) and norepinephrine (NE), whereas MAO-B preferentially oxidizes phenylethylamine (PEA). MAO-A KO mice have elevated brain levels of 5-HT, NE, and DA and manifest aggressive behavior; MAO-B KO mice show increased PEA only and do not exhibit aggression, demonstrating distinct substrate specificities and behavioral roles for the two isoenzymes.\",\n      \"method\": \"MAO-A and MAO-B knockout mice (transgenic deletion and homologous recombination), neurochemical measurements of brain monoamine levels, behavioral assays\",\n      \"journal\": \"Neurobiology (Budapest)\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 / Strong — two independent KO models with neurochemical and behavioral endpoints, directly comparing MAO-A vs MAO-B substrate selectivity in vivo\",\n      \"pmids\": [\"10591056\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1988,\n      \"finding\": \"The human MAOA gene was mapped to chromosomal region Xp21-p11 using rodent-human somatic cell hybrids, and the gene encodes an enzyme located in the outer mitochondrial membrane responsible for degradative metabolism of biogenic amines throughout the body. An RFLP was identified for this locus.\",\n      \"method\": \"Southern blot analysis, rodent-human somatic cell hybrids, chromosomal mapping\",\n      \"journal\": \"Genomics\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — direct chromosomal localization by somatic cell hybrid panel; widely replicated finding\",\n      \"pmids\": [\"2906043\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1996,\n      \"finding\": \"Mutational analysis of the human MAOA coding sequence in 40 control males with >100-fold variation in MAO-A enzyme activity (measured in cultured skin fibroblasts) revealed high conservation, with only 5 polymorphisms, all but one at synonymous positions. The one amino acid change (Lys→Arg) was neutral, demonstrating that coding sequence variation does not account for normal population variation in MAO-A activity.\",\n      \"method\": \"RT-PCR, SSCP, sequencing of mRNA/genomic DNA, MAO-A activity assay in cultured skin fibroblasts\",\n      \"journal\": \"American journal of medical genetics\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — direct enzymatic activity measurement correlated with coding sequence in 40 individuals; single lab but multiple methods\",\n      \"pmids\": [\"8678123\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2016,\n      \"finding\": \"Elucidation of the molecular structure of the active sites of MAO-A and MAO-B has enabled precise determination of how substrates and inhibitor molecules are metabolized or inhibit substrate metabolism. Reversible MAO-A inhibitors (e.g., moclobemide) lack the 'cheese effect' (tyramine pressor potentiation) seen with irreversible inhibitors, attributed to differences in binding mechanism at the active site.\",\n      \"method\": \"Review of crystal structure data and pharmacological characterization of inhibitor-enzyme interactions\",\n      \"journal\": \"Frontiers in pharmacology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 1 / Weak — structural and pharmacological data synthesized in review; active-site structure established by original crystallography studies cited therein but not primary data in this paper\",\n      \"pmids\": [\"27803666\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"Meta-analysis and systematic review established that the MAOA 5' VNTR polymorphism is robustly associated with MAO-A enzyme activity (medium to large effect), confirming that this promoter VNTR is a functional polymorphism that directly affects the abundance/activity of the MAOA gene product.\",\n      \"method\": \"Systematic review and meta-analysis of 255 eligible studies measuring polymorphism effects on gene product expression, abundance, activity, or affinity\",\n      \"journal\": \"Biological psychiatry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — meta-analysis of multiple independent studies measuring enzyme activity directly; robust and replicated across many labs\",\n      \"pmids\": [\"31303260\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2015,\n      \"finding\": \"MAOA promotes prostate cancer cell invasion through a MAOA/mTOR/HIF-1α signaling pathway that exploits reactive oxygen species (ROS). Cancer-associated fibroblasts (CAFs) induce prostate cancer EMT and invasion via this pathway, and curcumin abrogates CAF-induced invasion by inhibiting MAOA/mTOR/HIF-1α signaling and suppressing ROS production.\",\n      \"method\": \"In vitro invasion and EMT assays, ROS measurement, CXCR4 and IL-6 receptor expression analysis, pharmacological inhibition with curcumin\",\n      \"journal\": \"International journal of oncology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 3 / Moderate — multiple in vitro assays in single lab; pathway placement via pharmacological inhibition without genetic rescue\",\n      \"pmids\": [\"26499200\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2018,\n      \"finding\": \"Loss of MAOA in prostate epithelia (Pten/MAOA double KO mouse model) significantly decreases prostate tumor size and invasive cancer incidence, reduces AKT phosphorylation and Ki67, and suppresses cancer stem cell markers (OCT4, NANOG, CD44, α2β1, CD133, HIF-1α). Targeted MAOA knockdown (shRNA/siRNA) in prostate cancer cells confirms reduced spheroid formation, establishing that MAOA promotes cell proliferation and cancer stem cell maintenance via the PTEN/AKT pathway.\",\n      \"method\": \"Conditional prostate-specific double knockout mouse model (Pten/MAOA KO), shRNA knockdown, siRNA knockdown, colony formation assay, immunohistochemistry for stem cell markers, Western blot for AKT phosphorylation\",\n      \"journal\": \"Oncogene\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — in vivo genetic KO model plus multiple in vitro genetic knockdown approaches with orthogonal readouts; single lab but multiple methods\",\n      \"pmids\": [\"29844571\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2021,\n      \"finding\": \"MAOA promotes perineural invasion (PNI) of prostate cancer cells through a mechanism whereby MAOA activates SEMA3C transcription in a Twist1-dependent manner; SEMA3C then stimulates cMET via autocrine/paracrine interaction with co-activated PlexinA2 and NRP1 co-receptors. MAOA inhibitor treatment reduces PNI in vitro and tumor-infiltrating nerve fiber density in an orthotopic xenograft model.\",\n      \"method\": \"In vitro PNI assay, orthotopic xenograft mouse model, gene expression analysis, MAOA inhibitor treatment, mechanistic pathway dissection\",\n      \"journal\": \"Oncogene\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — in vitro and in vivo models, defined molecular pathway (MAOA→Twist1→SEMA3C→PlexinA2/NRP1→cMET) with multiple orthogonal approaches\",\n      \"pmids\": [\"33420365\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2020,\n      \"finding\": \"MAOA in stromal fibroblasts elevates reactive oxygen species production, triggers IL-6 activation, and promotes prostate tumorigenesis via paracrine IL-6/STAT3 signaling. Mechanistically, MAOA enhances IL-6 transcription through direct Twist1 binding to a conserved E-box element at the IL-6 promoter. Downstream STAT3 transcriptionally activates CD44 expression in prostate cancer cells.\",\n      \"method\": \"In vitro co-culture, in vivo tumor models, ChIP (Twist1 binding to IL-6 promoter E-box), Western blot, tissue microarray analysis\",\n      \"journal\": \"Oncogene\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — direct ChIP evidence for Twist1-E-box interaction, in vitro and in vivo models, paracrine signaling mechanism defined with multiple methods\",\n      \"pmids\": [\"32066880\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2021,\n      \"finding\": \"MAOA and androgen receptor (AR) form a positive feedback regulatory circuit in prostate cancer: androgens induce MAOA expression through direct AR binding to a novel intronic androgen response element (ARE) in the MAOA gene; in turn, MAOA promotes AR transcriptional activity via upregulation of Shh/Gli-YAP1 signaling, enhancing nuclear YAP1-AR interactions. Silencing MAOA suppresses AR-mediated prostate cancer growth including CRPC in mice.\",\n      \"method\": \"ChIP (AR binding to intronic ARE), reporter assay, siRNA/shRNA silencing, in vivo mouse models (androgen-dependent and CRPC), pharmacological combination studies\",\n      \"journal\": \"Cancer research\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — direct ChIP evidence for AR-ARE binding, multiple genetic and pharmacological approaches, in vitro and in vivo validation of pathway\",\n      \"pmids\": [\"34167949\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2017,\n      \"finding\": \"MAOA is a direct target gene of REST (repressor element-1 silencing transcription factor) in prostate cancer cells. Overexpressed MAOA produces reactive oxygen species (ROS) that inhibit apoptosis and activate autophagy in neuroendocrine-differentiated prostate cancer cells. MAOA inhibitors reduce neuroendocrine differentiation and autophagy activation.\",\n      \"method\": \"Reporter assay, siRNA knockdown, MAOA inhibitor treatment, ROS measurement, apoptosis and autophagy assays\",\n      \"journal\": \"Scientific reports\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 3 / Moderate — single lab, multiple in vitro assays; REST-MAOA direct target relationship established by reporter assay\",\n      \"pmids\": [\"28402333\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2018,\n      \"finding\": \"In breast cancer, IL-6/IL-6R signaling in hypoxic conditions causes sustained inhibition of MAO-A. Inhibition of IL-6R signaling or IL-6R siRNA increased MAO-A activity and inhibited tumor angiogenesis and invasion. Elevation of MAO-A with 5-azacytidine modulated IL-6-mediated angiogenesis and invasive signatures (VEGF, MMPs, EMT). This establishes MAO-A as a suppressor of tumor angiogenesis and invasion downstream of IL-6/IL-6R in hypoxic breast cancer.\",\n      \"method\": \"In vitro and in vivo assays, IL-6R siRNA knockdown, 5-azacytidine treatment, VEGF/MMP/EMT marker analysis, clinical specimen IHC\",\n      \"journal\": \"British journal of cancer\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 3 / Moderate — multiple in vitro and in vivo methods; IL-6R→MAO-A axis supported by siRNA knockdown and pharmacological elevation in single lab\",\n      \"pmids\": [\"29695771\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2018,\n      \"finding\": \"IL-13 stimulation of primary human monocytes and A549 lung carcinoma cells co-induces MAO-A expression with 15-lipoxygenase (15-LO). MAO-A gene expression and activity are regulated by STAT1, STAT3, STAT6, EGR1, and CREB. In monocytes and A549 cells, IL-13-driven MAO-A expression, activity, and function (including cell migration and ROS generation) are governed by 15-LO in a PPARγ-dependent manner, with STAT6 facilitating PPARγ transcriptional activity (IL-13→STAT6→15-LO→PPARγ→MAO-A axis).\",\n      \"method\": \"Primary human monocyte culture, A549 cell line, siRNA knockdown of STAT1/3/6, EGR1, CREB, 15-LO; MAO-A activity assay, ROS measurement, cell migration assay, reporter assay\",\n      \"journal\": \"Journal of Biological Chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — multiple transcription factor knockdowns with enzymatic activity measurements, two cell types, defined IL-13→STAT6→15-LO→PPARγ→MAO-A pathway\",\n      \"pmids\": [\"30021838\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2012,\n      \"finding\": \"Acute psychosocial stress in healthy humans reduces whole-brain MAO-A binding (measured by [11C]harmine PET) in 10 of 11 brain regions. Correspondingly, acute dexamethasone exposure in human neuronal and glial cell lines decreases MAO-A activity and protein levels within 4 hours. This establishes that glucocorticoid signaling acutely downregulates MAO-A density and activity.\",\n      \"method\": \"[11C]harmine PET imaging in humans under acute stress, Western blot for MAO-A protein, [14C]-5-HT metabolism assay for MAO-A activity in neuronal/glial cell lines after dexamethasone exposure\",\n      \"journal\": \"Journal of Neuroscience\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 / Strong — in vivo PET imaging plus in vitro enzymatic activity assay with protein quantification; convergent human and cell-based evidence for glucocorticoid-mediated acute MAO-A downregulation\",\n      \"pmids\": [\"23197705\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2006,\n      \"finding\": \"MAOA is subject to monoallelic expression (X chromosome inactivation) in primary clonal cultures of human skin fibroblasts, as determined by RFLP analysis of clonal cell lines. This establishes that MAOA undergoes X-inactivation in normal human somatic cells, with implications for sex differences in MAO-A-related traits.\",\n      \"method\": \"Primary clonal cell cultures from human skin fibroblasts, RFLP analysis of allelic expression\",\n      \"journal\": \"Biochemical and biophysical research communications\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — direct allele-specific expression analysis in primary clonal cultures; single lab, single method\",\n      \"pmids\": [\"16890910\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2009,\n      \"finding\": \"X chromosome inactivation (XCI) status of MAOA was confirmed in normal human fibroblasts with skewed inactivation using allele-specific expression analysis and DNA methylation of the 5' end, demonstrating monoallelic expression and refuting earlier hybrid cell data suggesting escape from XCI.\",\n      \"method\": \"Human fibroblasts with skewed XCI, allele-specific expression analysis, DNA methylation analysis of 5' region\",\n      \"journal\": \"Epigenetics\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — two complementary methods (allele-specific expression and DNA methylation) in normal human cells; single lab\",\n      \"pmids\": [\"19684479\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2018,\n      \"finding\": \"Luciferase-based reporter gene assays demonstrated that methylation of the MAOA promoter region causes decreased reporter gene activity compared with unmethylated constructs, directly establishing that DNA methylation of the MAOA promoter functionally reduces MAOA transcription.\",\n      \"method\": \"Luciferase reporter gene assay using methylated vs. unmethylated pCpGfree_MAOA constructs\",\n      \"journal\": \"International journal of neuropsychopharmacology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 1 / Weak — in vitro reporter assay establishing functional consequence of MAOA methylation; single lab, single method\",\n      \"pmids\": [\"30169842\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2023,\n      \"finding\": \"MAOA interacts with NDRG1 and suppresses the Warburg effect (glycolysis) in gastric cancer through inhibition of the PI3K/AKT/mTOR pathway. MAOA expression was negatively correlated with SUVmax values on PET-CT, and overexpression of MAOA promoted cancer cell apoptosis and inhibited tumor growth and glycolysis.\",\n      \"method\": \"Co-immunoprecipitation/protein interaction (MAOA-NDRG1), Western blot, Seahorse metabolic assay, in vitro and in vivo experiments, PI3K/AKT/mTOR pathway analysis\",\n      \"journal\": \"Cellular oncology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 3 / Moderate — protein interaction and pathway placement established in single lab with multiple assays including metabolic measurement; mechanism partially defined\",\n      \"pmids\": [\"37249744\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2021,\n      \"finding\": \"MAO-A expression and activity are increased in the pulmonary vasculature of patients with PAH and in experimental PAH. Clorgyline (MAO-A inhibitor) treatment reduced RV afterload, pulmonary vascular remodeling, proliferation, and oxidative stress in SuHx rats, establishing that MAO-A promotes pulmonary vascular remodeling via ROS production.\",\n      \"method\": \"Human PAH lung tissue analysis, SuHx rat model, pulmonary trunk banding rat model, echocardiography, RV catheterization, clorgyline pharmacological inhibition, histological analysis\",\n      \"journal\": \"American journal of respiratory cell and molecular biology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — in vivo animal models with pharmacological inhibition and multiple physiological/histological endpoints; single lab\",\n      \"pmids\": [\"33264068\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2024,\n      \"finding\": \"Glucocorticoids activate the PI3K/AKT pathway, which upregulates MAOA expression in trabecular meshwork cells; elevated MAOA then drives mitochondrial dysfunction, ROS production, and premature cellular senescence. PI3K inhibition or selective PIK3R1 silencing reduced DEX-induced MAOA expression and oxidative stress, placing MAOA downstream of PI3K/AKT in the glucocorticoid-induced senescence pathway.\",\n      \"method\": \"mRNA-seq/KEGG pathway analysis, PI3K inhibitor treatment, PIK3R1 siRNA silencing, ROS/mitochondrial superoxide measurement, cell cycle analysis, β-galactosidase staining, in vivo GIG mouse model\",\n      \"journal\": \"Aging cell\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — PI3K inhibition and genetic silencing with multiple cellular readouts; pathway placement of MAOA downstream of PI3K/AKT established in single lab\",\n      \"pmids\": [\"39688282\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2025,\n      \"finding\": \"Inhibition of stromal MAOA leads to increased WNT5A production in cancer-associated fibroblasts (CAFs), which activates CD8+ T cell cytotoxic capacity through Ca2+-NFATC1 signaling, thereby improving the immunosuppressive tumor microenvironment. MAOA inhibition in stromal cells also promotes conversion of myofibroblastic CAFs and synergizes with immune checkpoint inhibitors.\",\n      \"method\": \"Single-cell sequencing re-analysis, in vitro co-culture of stromal and immune cells, C57BL/6J subcutaneous tumor model, dual humanized mouse model, MAOA inhibitor treatment\",\n      \"journal\": \"Journal for immunotherapy of cancer\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — in vitro and in vivo models with mechanistic pathway (stromal MAOA→WNT5A→Ca2+-NFATC1→CD8+ T cell activation) defined in single lab\",\n      \"pmids\": [\"40121032\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2023,\n      \"finding\": \"TPhP (triphenyl phosphate) activates MAOA, leading to oxidative stress that activates NFκB and disrupts tryptophan metabolism (inhibiting tryptophan-serotonin pathway, activating tryptophan-kynurenine pathway) in trophoblast cells and mouse placenta. The MAOA inhibitor clorgyline mitigated TPhP-induced oxidative stress and reversed tryptophan metabolism disturbances, establishing MAOA as a key mediator of TPhP-induced ROS/NFκB-dependent tryptophan pathway disruption.\",\n      \"method\": \"JEG-3 trophoblast cell line, mouse intrauterine exposure model, clorgyline pharmacological inhibition, NFκB inhibitor sulfasalazine, NAC antioxidant, gene/protein expression analysis, metabolite measurement\",\n      \"journal\": \"Science of the Total Environment\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — pharmacological inhibition with MAOA inhibitor and pathway-specific inhibitors, confirmed in vivo in mouse model; single lab\",\n      \"pmids\": [\"37659542\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2012,\n      \"finding\": \"ApoE isoforms regulate melatonin biosynthesis in C6 glioma cells partly through MAOA: ApoE4-expressing cells show decreased MAOA (and MAOB) mRNA expression compared to ApoE3 cells, leading to reduced serotonin degradation and increased availability of the melatonin precursor, contributing to higher melatonin levels in ApoE4 cells.\",\n      \"method\": \"Stable ApoE isoform expression in C6 cells, mRNA expression analysis, melatonin and NAT protein measurement\",\n      \"journal\": \"Journal of pineal research\",\n      \"confidence\": \"Low\",\n      \"confidence_rationale\": \"Tier 3 / Weak — single lab, single cell line, mRNA expression only without direct enzymatic activity measurement of MAOA\",\n      \"pmids\": [\"22225631\"],\n      \"is_preprint\": false\n    }\n  ],\n  \"current_model\": \"MAOA encodes a mitochondrial flavoenzyme anchored to the outer mitochondrial membrane that catalyzes the oxidative deamination of monoamine neurotransmitters (serotonin, norepinephrine, dopamine) and dietary amines, generating hydrogen peroxide as a byproduct; the gene is X-linked (Xp11.3) and subject to X-chromosome inactivation, its expression is controlled by a functional 5' VNTR promoter polymorphism and by DNA methylation, and its activity is acutely downregulated by glucocorticoids; beyond neurotransmitter metabolism, MAOA-derived ROS activates mTOR/HIF-1α, PI3K/AKT, and Twist1/IL-6/STAT3 signaling to drive cancer cell proliferation, stemness, EMT, perineural invasion (via SEMA3C/PlexinA2/NRP1/cMET), and an immunosuppressive tumor microenvironment, while in the cardiovascular system elevated MAO-A promotes pulmonary vascular remodeling through oxidative stress.\"\n}\n```","stage2_raw":"{\n  \"mechanistic_narrative\": \"MAOA encodes a flavoenzyme of the outer mitochondrial membrane that catalyzes the oxidative deamination of biogenic amines throughout the body [#2], and is the primary enzyme degrading serotonin and norepinephrine in vivo: its genetic loss in mice produces large elevations of brain serotonin and norepinephrine, cortical cytoarchitectural changes, and aggression that is reversible by blocking serotonin synthesis [#0]. MAO-A and MAO-B are distinguished by substrate preference, MAO-A favoring serotonin and norepinephrine [#1], with active-site structure determining substrate handling and the differential pharmacology of reversible versus irreversible inhibitors [#4]. The X-linked gene (Xp21-p11) is subject to X-chromosome inactivation in normal somatic cells [#2, #15, #16], and its expression is set largely at the regulatory rather than coding level: coding variation does not explain population activity differences [#3], whereas a functional 5' promoter VNTR governs enzyme activity [#5] and promoter DNA methylation suppresses transcription [#17]. Enzyme density and activity are acutely downregulated by glucocorticoid signaling, as shown by stress-induced reductions in brain MAO-A binding and dexamethasone-driven loss of MAO-A in neuronal and glial cells [#14]. Beyond neurotransmitter catabolism, MAO-A-generated reactive oxygen species drive oncogenic signaling: in prostate cancer MAOA promotes proliferation and cancer stem-cell maintenance through PTEN/AKT [#7], invasion through mTOR/HIF-1\\u03b1 [#6], paracrine IL-6/STAT3 signaling via Twist1 binding the IL-6 promoter [#9], perineural invasion through a Twist1\\u2192SEMA3C\\u2192PlexinA2/NRP1\\u2192cMET cascade [#8], and a positive feedback loop with the androgen receptor via an intronic ARE and Shh/Gli-YAP1 signaling [#10]. MAOA expression is itself controlled by transcription factors including REST [#11] and an IL-13\\u2192STAT6\\u219215-LO\\u2192PPAR\\u03b3 axis [#13]. Context-dependent roles also exist, with MAO-A acting as a suppressor of angiogenesis and invasion downstream of IL-6R in hypoxic breast cancer [#12] and restraining glycolysis through NDRG1 and PI3K/AKT/mTOR in gastric cancer [#18]. In non-malignant tissues, elevated MAO-A drives pulmonary vascular remodeling through oxidative stress [#19], glucocorticoid-induced senescence in trabecular meshwork cells downstream of PI3K/AKT [#20], and ROS/NF\\u03baB-dependent disruption of placental tryptophan metabolism [#22].\",\n  \"teleology\": [\n    {\n      \"year\": 1988,\n      \"claim\": \"Establishing the chromosomal location and subcellular identity of MAOA defined it as an X-linked outer-mitochondrial-membrane enzyme for biogenic amine catabolism.\",\n      \"evidence\": \"Southern blot and rodent-human somatic cell hybrid mapping to Xp21-p11\",\n      \"pmids\": [\"2906043\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Did not resolve substrate specificity versus MAO-B\", \"No functional consequence of gene dosage established\"]\n    },\n    {\n      \"year\": 1995,\n      \"claim\": \"Genetic ablation in mice answered whether MAOA is rate-limiting for serotonin/norepinephrine turnover in vivo and whether this drives behavior, placing elevated serotonin causally upstream of aggression.\",\n      \"evidence\": \"Transgene-insertion knockout mouse with neurochemical quantitation and pharmacological rescue by parachlorophenylalanine\",\n      \"pmids\": [\"7792602\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Knockout generated by transgene integration rather than clean targeted deletion\", \"Human relevance of behavioral phenotype not addressed\"]\n    },\n    {\n      \"year\": 1999,\n      \"claim\": \"Side-by-side comparison of MAO-A and MAO-B knockouts resolved the distinct substrate selectivities and behavioral roles of the two isoenzymes.\",\n      \"evidence\": \"MAO-A and MAO-B knockout mice with brain monoamine measurement and behavioral assays\",\n      \"pmids\": [\"10591056\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Did not define structural basis of substrate discrimination\"]\n    },\n    {\n      \"year\": 1996,\n      \"claim\": \"Mutational scanning answered whether normal variation in MAO-A activity arises from coding changes, showing it does not and pointing to regulatory variation.\",\n      \"evidence\": \"SSCP/sequencing of MAOA coding sequence correlated with fibroblast enzyme activity in 40 males\",\n      \"pmids\": [\"8678123\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Single cohort; did not identify the regulatory element responsible\", \"Activity measured only in fibroblasts\"]\n    },\n    {\n      \"year\": 2019,\n      \"claim\": \"Meta-analysis confirmed the 5' VNTR as a functional promoter polymorphism that sets MAO-A activity, anchoring the regulatory-variation hypothesis.\",\n      \"evidence\": \"Systematic review/meta-analysis of 255 studies of polymorphism effects on enzyme activity\",\n      \"pmids\": [\"31303260\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Mechanism by which VNTR copy number alters transcription not dissected here\"]\n    },\n    {\n      \"year\": 2009,\n      \"claim\": \"Allele-specific expression and methylation analyses settled whether MAOA escapes X-inactivation, establishing monoallelic expression and an epigenetic regulatory layer.\",\n      \"evidence\": \"Allele-specific expression and 5' DNA methylation analysis in skewed-XCI human fibroblasts (with prior clonal RFLP analysis)\",\n      \"pmids\": [\"19684479\", \"16890910\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Single tissue type (fibroblasts)\", \"Does not address tissue-specific escape in brain\"]\n    },\n    {\n      \"year\": 2018,\n      \"claim\": \"Reporter assays directly demonstrated that promoter methylation functionally represses MAOA transcription, linking epigenetic state to enzyme output.\",\n      \"evidence\": \"Luciferase reporter assay comparing methylated and unmethylated MAOA promoter constructs\",\n      \"pmids\": [\"30169842\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Single in vitro method\", \"Does not identify the methyltransferases or signals controlling promoter methylation in vivo\"]\n    },\n    {\n      \"year\": 2012,\n      \"claim\": \"Combined human PET imaging and cell-based assays established that glucocorticoid signaling acutely downregulates MAO-A density and activity, connecting stress physiology to enzyme regulation.\",\n      \"evidence\": \"[11C]harmine PET in stressed humans plus dexamethasone treatment with Western blot and 5-HT metabolism assay in neuronal/glial lines\",\n      \"pmids\": [\"23197705\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Transcriptional versus post-translational mechanism of acute downregulation not fully resolved\"]\n    },\n    {\n      \"year\": 2018,\n      \"claim\": \"Dissection of cytokine signaling defined an IL-13\\u2192STAT6\\u219215-LO\\u2192PPAR\\u03b3 axis and a panel of transcription factors (STAT1/3/6, EGR1, CREB) controlling MAO-A expression and activity in monocytes and lung cells.\",\n      \"evidence\": \"siRNA knockdowns of transcription factors and 15-LO with MAO-A activity, ROS, and migration assays in primary monocytes and A549 cells\",\n      \"pmids\": [\"30021838\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Generalizability of this axis beyond monocytes/A549 not established\"]\n    },\n    {\n      \"year\": 2017,\n      \"claim\": \"Identification of REST as a direct MAOA regulator and of ROS-driven autophagy/apoptosis effects linked MAOA transcriptional control to neuroendocrine prostate cancer phenotypes.\",\n      \"evidence\": \"Reporter assays, siRNA knockdown, MAOA inhibitor treatment with ROS, apoptosis and autophagy readouts\",\n      \"pmids\": [\"28402333\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Single lab, in vitro only\", \"Direct REST binding shown by reporter rather than endogenous occupancy\"]\n    },\n    {\n      \"year\": 2018,\n      \"claim\": \"A Pten/MAOA double-knockout model and knockdowns established that MAOA promotes prostate tumor growth and cancer stem-cell maintenance through PTEN/AKT signaling.\",\n      \"evidence\": \"Conditional prostate-specific double KO mouse, shRNA/siRNA knockdown, spheroid and colony assays, IHC for stemness markers\",\n      \"pmids\": [\"29844571\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether enzymatic ROS production is strictly required for the AKT effect not isolated\"]\n    },\n    {\n      \"year\": 2021,\n      \"claim\": \"Mechanistic studies built out the prostate cancer signaling network, defining MAOA-driven perineural invasion via Twist1\\u2192SEMA3C\\u2192PlexinA2/NRP1\\u2192cMET and a positive feedback loop with the androgen receptor through an intronic ARE and Shh/Gli-YAP1.\",\n      \"evidence\": \"ChIP, reporter assays, in vitro PNI assays, orthotopic and CRPC xenograft models with MAOA inhibitor and silencing\",\n      \"pmids\": [\"33420365\", \"34167949\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Relative contribution of enzymatic ROS versus non-catalytic functions to these transcriptional outputs not separated\"]\n    },\n    {\n      \"year\": 2020,\n      \"claim\": \"Stromal studies showed MAOA in fibroblasts drives prostate tumorigenesis by ROS-induced, Twist1-dependent IL-6 transcription feeding paracrine IL-6/STAT3 activation of CD44 in cancer cells.\",\n      \"evidence\": \"Co-culture, in vivo tumor models, ChIP of Twist1 at the IL-6 promoter E-box, tissue microarray\",\n      \"pmids\": [\"32066880\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"How MAO-A-derived ROS leads to Twist1 activation upstream of IL-6 not detailed\"]\n    },\n    {\n      \"year\": 2025,\n      \"claim\": \"Single-cell and co-culture work extended the stromal role, showing that inhibiting stromal MAOA raises WNT5A to activate CD8+ T-cell cytotoxicity via Ca2+-NFATC1 and relieve immunosuppression.\",\n      \"evidence\": \"Single-cell re-analysis, stromal-immune co-culture, syngeneic and humanized mouse tumor models with MAOA inhibitor\",\n      \"pmids\": [\"40121032\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Single lab\", \"Direct molecular link from MAOA loss to WNT5A induction not fully mapped\"]\n    },\n    {\n      \"year\": 2023,\n      \"claim\": \"Work in breast and gastric cancers revealed context-dependent tumor-suppressive roles, with MAO-A restrained downstream of IL-6R in hypoxic breast cancer and binding NDRG1 to suppress glycolysis via PI3K/AKT/mTOR in gastric cancer.\",\n      \"evidence\": \"IL-6R siRNA and 5-azacytidine in breast models; Co-IP, Seahorse, and in vivo gastric cancer models\",\n      \"pmids\": [\"29695771\", \"37249744\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Opposing pro- versus anti-tumor roles across tissues not mechanistically reconciled\", \"MAOA-NDRG1 interaction from single-lab Co-IP without reciprocal structural validation\"]\n    },\n    {\n      \"year\": 2024,\n      \"claim\": \"Non-malignant disease studies tied MAO-A-derived oxidative stress to pathology: pulmonary vascular remodeling in PAH, PI3K/AKT-dependent senescence in trabecular meshwork cells, and ROS/NF\\u03baB-dependent placental tryptophan metabolism disruption.\",\n      \"evidence\": \"SuHx and banding rat PAH models with clorgyline; PI3K inhibitor and PIK3R1 silencing in trabecular meshwork plus GIG mouse model; TPhP exposure with clorgyline in trophoblasts and placenta\",\n      \"pmids\": [\"33264068\", \"39688282\", \"37659542\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Each established in a single lab/model\", \"Causal sufficiency of MAO-A ROS versus correlation not fully isolated\"]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"It remains unresolved how much of MAOA's oncogenic and pathological signaling depends on its catalytic ROS generation versus non-enzymatic scaffolding functions, and what reconciles its opposing pro- and anti-tumor roles across tissues.\",\n      \"evidence\": \"\",\n      \"pmids\": [],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"No catalytically-dead mutant rescue separating ROS-dependent from independent functions\", \"No unifying model for tissue-specific tumor-promoting versus tumor-suppressing behavior\"]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0016491\", \"supporting_discovery_ids\": [0, 1, 2, 4]},\n      {\"term_id\": \"GO:0016787\", \"supporting_discovery_ids\": [0, 1, 2]}\n    ],\n    \"localization\": [\n      {\"term_id\": \"GO:0005739\", \"supporting_discovery_ids\": [2]}\n    ],\n    \"pathway\": [\n      {\"term_id\": \"R-HSA-112316\", \"supporting_discovery_ids\": [0, 1]},\n      {\"term_id\": \"R-HSA-1430728\", \"supporting_discovery_ids\": [1, 2, 18]},\n      {\"term_id\": \"R-HSA-162582\", \"supporting_discovery_ids\": [6, 7, 8, 9, 10]},\n      {\"term_id\": \"R-HSA-1643685\", \"supporting_discovery_ids\": [19, 20, 22]},\n      {\"term_id\": \"R-HSA-168256\", \"supporting_discovery_ids\": [21, 13]}\n    ],\n    \"complexes\": [],\n    \"partners\": [\"NDRG1\", \"Twist1\", \"AR\"],\n    \"other_free_text\": []\n  }\n}","audit_flag":null,"evaluation":{"pairwise":"tie","faith_supported":8,"faith_total":8,"faith_pct":100.0}}